Publications

MET409 a potent, non-bile acid sustained FXR agonist, shows rapid disease reversal in a diet-induced obese model of biopsy-confirmed NASH

Back
Poster presentation at AASLD – The Liver Meeting, November 2018

AASLD 2018 MET409

Download PDF